A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer

SIMPLE SUMMARY: The PACIFIC trial demonstrated the survival benefits of durvalumab consolidation (DC) in patients with unresectable stage III non–small cell lung cancer (NSCLC). In this retrospective cohort study, using a propensity score-matched analysis, we investigated the effectiveness of DC aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Cheol-Kyu, Jeon, Nakyung, Park, Hwa-Kyung, Oh, Hyung-Joo, Kim, Young-Chul, Jeon, Ha-Lim, Kim, Yong-Hyub, Ahn, Sung-Ja, Oh, In-Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000649/
https://www.ncbi.nlm.nih.gov/pubmed/36900397
http://dx.doi.org/10.3390/cancers15051606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000649/
https://www.ncbi.nlm.nih.gov/pubmed/36900397
http://dx.doi.org/10.3390/cancers15051606

Ejemplares similares